Product
Balfaxar
1 clinical trial
2 indications
Indication
Vitamin K-dependent coagulation defectIndication
Bleeding RiskClinical trial
Post Marketing Observational Study on Safety of BALFAXAR® vs. KCENTRA for Reversal of Vitamin K Antagonist Induced Anticoagulation in Adults Undergoing Urgent Surgery or Invasive Procedure.Status: Not yet recruiting, Estimated PCD: 2031-12-31